| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/2007 | CA2258725C Analogues or derivatives of quercetin (prodrugs) |
| 07/31/2007 | CA2258683C Oral composition comprising a triazole antifungal compound |
| 07/31/2007 | CA2255913C The use of buckminsterfullerene for treatment of neurotoxic injury |
| 07/31/2007 | CA2227688C Methods and compositions for inhibition of viral replication |
| 07/31/2007 | CA2223397C Novel nor-pregnanes for inducing hypothalamic effects |
| 07/31/2007 | CA2217767C Low ph skin-treatment composition |
| 07/31/2007 | CA2214480C The production of carotenoid preparations in the form of coldwater-dispersible powders, and the use of the novel carotenoid preparations |
| 07/31/2007 | CA2212118C Piperidinyl-2-alkyl subst. linear polyamines for the reduction of intracellular, endogenic polyamine levels such as putrescine, spermidine and spermine, and their impact on cell proliferation |
| 07/31/2007 | CA2191645C Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders |
| 07/31/2007 | CA2186260C Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide |
| 07/31/2007 | CA2184802C Process for manufacture of imidazo benzodiazepine derivatives |
| 07/31/2007 | CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2162530C Novel crystalline cephem acid addition salts and processes for their preparation |
| 07/31/2007 | CA2160767C Injectable microdispersions for soft tissue repair and augmentation |
| 07/31/2007 | CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2100745C Amylin agonist peptides and uses therefor |
| 07/31/2007 | CA1341537C Production of pluripotent granulocyte colony-stimulating factor |
| 07/26/2007 | WO2007085020A2 Method of treating atrophic vaginitis |
| 07/26/2007 | WO2007084964A2 Pharmaceutical composition comprising a protein pump inhibitor and protein component |
| 07/26/2007 | WO2007084914A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists |
| 07/26/2007 | WO2007084875A2 Spiro compounds and methods of use |
| 07/26/2007 | WO2007084868A2 Treatment of disorders by activation of the unfolded protein response |
| 07/26/2007 | WO2007084857A2 Methods and compositions for treating cell proliferative disorders |
| 07/26/2007 | WO2007084853A2 Methods for inhibiting osteoclastogenesis |
| 07/26/2007 | WO2007084841A2 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 07/26/2007 | WO2007084839A2 Dietary methods and compositions for enhancing metabolism and reducting reactive oxygen species |
| 07/26/2007 | WO2007084815A2 Substituted thienopyrimidine kinase inhibitors |
| 07/26/2007 | WO2007084786A1 Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 07/26/2007 | WO2007084777A2 Multi-parameter monitoring device for use with central and intravenous administration of medication |
| 07/26/2007 | WO2007084769A2 Microalgae-derived compositions for improving the health and appearance of skin |
| 07/26/2007 | WO2007084765A2 Injectable combination therapy for eye disorders |
| 07/26/2007 | WO2007084761A1 Maleate salt of tegaserod and crystalline forms thereof |
| 07/26/2007 | WO2007084728A2 2-imino-benzimidazoles |
| 07/26/2007 | WO2007084721A2 Skin protection and moisturizing compositions and methods |
| 07/26/2007 | WO2007084670A2 Specific therapy using integrin ligands for treating cancer |
| 07/26/2007 | WO2007084667A2 Fused heterobicyclic kinase inhibitors |
| 07/26/2007 | WO2007084661A2 Therapy-enhancing glucan |
| 07/26/2007 | WO2007084655A2 Method for rapid detection and evaluation of cultured cell growth |
| 07/26/2007 | WO2007084651A2 Methods and kits to treat chronic inflammatory immune diseases |
| 07/26/2007 | WO2007084650A2 Single-dose needle-free administration of antithrombotic medications |
| 07/26/2007 | WO2007084648A2 Mixed 4→6 procyanidin dimers and their use |
| 07/26/2007 | WO2007084625A2 Novel compounds and methods for inhibiting p53 activity |
| 07/26/2007 | WO2007084622A2 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof |
| 07/26/2007 | WO2007084614A2 Hair growth formula |
| 07/26/2007 | WO2007084610A2 Polyurethanes for osteoimplants |
| 07/26/2007 | WO2007084591A2 Novel solid forms of (4r)-1-[4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl]-1,2,3,5-tetrahydro-spiro[4h-1-benzazepine-4,1'-[2]cyclopentene]-3'-carboxylic acid |
| 07/26/2007 | WO2007084560A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH |
| 07/26/2007 | WO2007084557A2 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | WO2007084548A2 Viral treatment |
| 07/26/2007 | WO2007084542A2 Treatment of inflammatory disorders with triazole compounds |
| 07/26/2007 | WO2007084541A2 Central administration of stable formulations of therapeutic agents for cns conditions |
| 07/26/2007 | WO2007084535A2 Neuronal nicotinic receptor ligands and their use |
| 07/26/2007 | WO2007084532A2 Combination therapy with parp inhibitors |
| 07/26/2007 | WO2007084498A1 Piperazine derivatives as farnesyl protein transferase inhibitors |
| 07/26/2007 | WO2007084473A2 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals |
| 07/26/2007 | WO2007084468A2 Photodynamic cosmetic procedure and healing method |
| 07/26/2007 | WO2007084464A2 Water channel blockers and methods of use thereof |
| 07/26/2007 | WO2007084455A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 07/26/2007 | WO2007084452A2 Non-leaching surface-active film compositions for microbial adhesion prevention |
| 07/26/2007 | WO2007084451A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 07/26/2007 | WO2007084424A2 Treatment of substance abuse |
| 07/26/2007 | WO2007084419A2 Inhibition of inflammatory cytokine production with tanshinones |
| 07/26/2007 | WO2007084394A2 2,5 diaza-bicyclo[2.2.1]heptane derivatives as calcium channel blockers |
| 07/26/2007 | WO2007084332A2 Memantine for the normalization of visual acuity deficits |
| 07/26/2007 | WO2007084331A2 Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
| 07/26/2007 | WO2007084290A2 Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain |
| 07/26/2007 | WO2007084247A2 Stable therapeutic formulations |
| 07/26/2007 | WO2007084233A2 Pharmaceutical formulations comprising 17-allylamino-17-demethoxygeldanamycin |
| 07/26/2007 | WO2007084231A2 Treatment of inflammation and organ dysfunction |
| 07/26/2007 | WO2007084211A2 Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception |
| 07/26/2007 | WO2007084136A2 Treatment of acute respiratory distress syndrome |
| 07/26/2007 | WO2007084135A2 Inhibitors of checkpoint kinases |
| 07/26/2007 | WO2007084127A1 Use of gluten for wound treatment as active healing ingredient |
| 07/26/2007 | WO2007084073A1 Novel compounds and use thereof |
| 07/26/2007 | WO2007084059A1 A food composition comprising amino acids |
| 07/26/2007 | WO2007083985A1 Synergistic pharmaceutical composition of diclofenac and lysine clonixinate |
| 07/26/2007 | WO2007083908A1 A method for preparing decursinol from angelica gigas with high yield |
| 07/26/2007 | WO2007083823A1 Androgen receptor-binding activity of genoderma mushroom-treated product |
| 07/26/2007 | WO2007083821A1 Anti-overstrain composition |
| 07/26/2007 | WO2007083689A1 Plasminogen activator inhibitor-1 inhibitor |
| 07/26/2007 | WO2007083679A1 Novel film-coated tablet |
| 07/26/2007 | WO2007083640A1 Preventive or remedy for increased urinary frequency and urinary incontinence |
| 07/26/2007 | WO2007083634A1 Therapeutic agent for traumatic neuropathy and/or movement disorder |
| 07/26/2007 | WO2007083631A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 07/26/2007 | WO2007083594A1 Laxative and food containing the same |
| 07/26/2007 | WO2007083522A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier |
| 07/26/2007 | WO2007083402A1 Nutritional supplement for promotion of hair growth and/or hair restoration |
| 07/26/2007 | WO2007083239A1 Pyridine derivatives as sodium channel modulators |
| 07/26/2007 | WO2007083228A1 Overall therapeutic approach in the treatment of neurodegenerative diseases |
| 07/26/2007 | WO2007083146A2 The treatment of cognitive and psychotic disorders |
| 07/26/2007 | WO2007083145A1 The treatment of ocular conditions and the systemic side-effects of glucocorticoids |
| 07/26/2007 | WO2007083119A2 Methods |
| 07/26/2007 | WO2007083114A1 Alchemix for the treatment of cancer |
| 07/26/2007 | WO2007083101A2 Use in an alternative treatment of cancer |
| 07/26/2007 | WO2007083098A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/26/2007 | WO2007083094A1 Prevention/treatment of ichthyosis vulgaris, atopy and other disorders |
| 07/26/2007 | WO2007083089A1 Chemical compounds |
| 07/26/2007 | WO2007082979A1 A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| 07/26/2007 | WO2007082978A1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| 07/26/2007 | WO2007082974A1 Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same |